Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Xgeva

Amgen’s Xgeva delays prostate cancer bone pain

A clinical trial of Amgen Inc’s bone drug, Xgeva, found that it can significantly delay the time it takes for prostate cancer to cause bone pain—a finding the company believes will help boost the drug’s market potential.

Amgen said in December that monthly injections of Xgeva, also known as denosumab, added 4.2 months, compared… Amgen’s Xgeva delays prostate cancer bone pain   



kidney infection4 - radical nephrectomy4 - demeclocycline1 - ct3 prostate cancer1 - cisplatin1 - kidney donor2 - antibiotic treatment1 - cancerous prostate glands1 - pelvic floor4 - overactive bladder syndrome1 - urinary catheters1 - perineal laxity3 - low carbohydrate diet1 - chronic hereditary nephritis1 - renal replacement treatment1 - proton therapy1 - testicular cancer1 - kit kat1 - super acid1 - weight loss2 - overactive bladder9 - prostate surgery4 - minimally invasive laparoscopic treatment of prostate cancer1 - berger's disease1 - biopsy outcome1 - renal agenesis1 - journal of the american society of nephrology4 - enzalutamide1 - hyperlipidemia1 - treatment of prostate cancer1 -